APW
CRBP icon

Atlantic Private Wealth’s Corbus Pharmaceuticals CRBP Stock Holding History

Atlantic Private Wealth’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.69K Buy
+500
New +$4.73K ﹤0.01% 196

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Atlantic Private Wealth's CRBP Position: Q2 2026 in Review

Atlantic Private Wealth opened a new position in Corbus Pharmaceuticals (CRBP) in Q2 2026: 500 shares worth $4.69K. The stake represents ﹤0.01% of the portfolio and ranks #196 among its holdings.

107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Atlantic Private Wealth held 500 shares of Corbus Pharmaceuticals worth $4.69K as of Q2 2026.
  • Corbus Pharmaceuticals was a new Atlantic Private Wealth position in Q2 2026.
  • Corbus Pharmaceuticals made up ﹤0.01% of Atlantic Private Wealth's portfolio in Q2 2026, its #196 holding.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Atlantic Private Wealth's 13F filing for Q2 2026, filed 11 Aug 2026.